226 related articles for article (PubMed ID: 20005148)
1. Pathways mediating VEGF-independent tumor angiogenesis.
Ferrara N
Cytokine Growth Factor Rev; 2010 Feb; 21(1):21-6. PubMed ID: 20005148
[TBL] [Abstract][Full Text] [Related]
2. Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies.
Crawford Y; Ferrara N
Trends Pharmacol Sci; 2009 Dec; 30(12):624-30. PubMed ID: 19836845
[TBL] [Abstract][Full Text] [Related]
3. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
4. Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis.
Ferrara N
Curr Opin Hematol; 2010 May; 17(3):219-24. PubMed ID: 20308892
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor as a survival factor in tumor-associated angiogenesis.
Affara NI; Robertson FM
In Vivo; 2004; 18(5):525-42. PubMed ID: 15523889
[TBL] [Abstract][Full Text] [Related]
6. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
Hicklin DJ; Ellis LM
J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
[TBL] [Abstract][Full Text] [Related]
7. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
Ciulla TA; Rosenfeld PJ
Curr Opin Ophthalmol; 2009 May; 20(3):166-74. PubMed ID: 19381089
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor--a positive and negative regulator of tumor growth.
Vecchiarelli-Federico LM; Cervi D; Haeri M; Li Y; Nagy A; Ben-David Y
Cancer Res; 2010 Feb; 70(3):863-7. PubMed ID: 20103650
[TBL] [Abstract][Full Text] [Related]
9. VEGF as an inhibitor of tumor vessel maturation: implications for cancer therapy.
Greenberg JI; Cheresh DA
Expert Opin Biol Ther; 2009 Nov; 9(11):1347-56. PubMed ID: 19761418
[TBL] [Abstract][Full Text] [Related]
10. Targeting tumor angiogenesis.
Gaur P; Bose D; Samuel S; Ellis LM
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S12-9. PubMed ID: 19393831
[TBL] [Abstract][Full Text] [Related]
11. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
Shibuya M
FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor.
Ferrara N
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):789-91. PubMed ID: 19164810
[TBL] [Abstract][Full Text] [Related]
13. Pathways mediating resistance to vascular endothelial growth factor-targeted therapy.
Ellis LM; Hicklin DJ
Clin Cancer Res; 2008 Oct; 14(20):6371-5. PubMed ID: 18927275
[TBL] [Abstract][Full Text] [Related]
14. Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis.
Viloria-Petit A; Crombet T; Jothy S; Hicklin D; Bohlen P; Schlaeppi JM; Rak J; Kerbel RS
Cancer Res; 2001 Jul; 61(13):5090-101. PubMed ID: 11431346
[TBL] [Abstract][Full Text] [Related]
15. Sex-steroid regulation of vascular endothelial growth factor in breast cancer.
Hyder SM
Endocr Relat Cancer; 2006 Sep; 13(3):667-87. PubMed ID: 16954424
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.
Casanovas O; Hicklin DJ; Bergers G; Hanahan D
Cancer Cell; 2005 Oct; 8(4):299-309. PubMed ID: 16226705
[TBL] [Abstract][Full Text] [Related]
17. [VEGF, anti-vEGF and diseases].
Corvol P
Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
[TBL] [Abstract][Full Text] [Related]
18. Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cells.
Shojaei F; Ferrara N
Cancer Res; 2008 Jul; 68(14):5501-4. PubMed ID: 18632597
[TBL] [Abstract][Full Text] [Related]
19. [Tumor angiogenesis].
Bikfalvi A
Bull Cancer; 2007; 94(7 Suppl):F193-8. PubMed ID: 17964996
[TBL] [Abstract][Full Text] [Related]
20. Managing tumor angiogenesis: lessons from VEGF-resistant tumors and wounds.
Cuevas I; Boudreau N
Adv Cancer Res; 2009; 103():25-42. PubMed ID: 19854351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
